Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
21 08 2023
21 08 2023
Historique:
received:
17
02
2023
accepted:
02
08
2023
medline:
23
8
2023
pubmed:
22
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Pronounced immune escape by the SARS-CoV-2 Omicron variant has resulted in many individuals possessing hybrid immunity, generated through a combination of vaccination and infection. Concerns have been raised that omicron breakthrough infections in triple-vaccinated individuals result in poor induction of omicron-specific immunity, and that prior SARS-CoV-2 infection is associated with immune dampening. Taking a broad and comprehensive approach, we characterize mucosal and blood immunity to spike and non-spike antigens following BA.1/BA.2 infections in triple mRNA-vaccinated individuals, with and without prior SARS-CoV-2 infection. We find that most individuals increase BA.1/BA.2/BA.5-specific neutralizing antibodies following infection, but confirm that the magnitude of increase and post-omicron titres are higher in the infection-naive. In contrast, significant increases in nasal responses, including neutralizing activity against BA.5 spike, are seen regardless of infection history. Spike-specific T cells increase only in infection-naive vaccinees; however, post-omicron T cell responses are significantly higher in the previously-infected, who display a maximally induced response with a highly cytotoxic CD8+ phenotype following their 3
Identifiants
pubmed: 37604803
doi: 10.1038/s41467-023-40592-4
pii: 10.1038/s41467-023-40592-4
pmc: PMC10442364
doi:
Substances chimiques
COVID-19 Vaccines
0
Antibodies, Viral
0
Antibodies, Neutralizing
0
Immunoglobulin A
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5065Informations de copyright
© 2023. Springer Nature Limited.
Références
J Clin Invest. 2022 Dec 1;132(23):
pubmed: 36219482
Cell Rep. 2022 Oct 18;41(3):111496
pubmed: 36261003
Cell. 2022 Nov 10;185(23):4333-4346.e14
pubmed: 36257313
Science. 2022 Aug 19;377(6608):890-894
pubmed: 35857529
Nat Rev Immunol. 2022 Feb;22(2):69-71
pubmed: 35046570
Lancet Microbe. 2022 Jan;3(1):e21-e31
pubmed: 34778853
Clin Infect Dis. 2018 Oct 30;67(10):1523-1532
pubmed: 29672713
Nat Commun. 2023 Aug 21;14(1):5065
pubmed: 37604803
Virus Evol. 2022 Mar 18;8(1):veac023
pubmed: 35502202
Clin Exp Immunol. 2022 Jul 22;209(1):90-98
pubmed: 35522978
Lancet Infect Dis. 2023 Feb;23(2):167-176
pubmed: 36270311
Front Immunol. 2022 Sep 08;13:953949
pubmed: 36159846
Patterns (N Y). 2021 Jan 08;2(1):100178
pubmed: 33511368
Science. 2022 Jul 15;377(6603):eabq1841
pubmed: 35699621
Eur J Immunol. 2022 Aug;52(8):1297-1307
pubmed: 35416291
Science. 2022 Mar 25;375(6587):1406-1411
pubmed: 35133177
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Science. 2022 Nov 11;378(6620):619-627
pubmed: 36264829
N Engl J Med. 2022 Sep 8;387(10):953-954
pubmed: 36044619
PLoS Pathog. 2019 Dec 19;15(12):e1008109
pubmed: 31856206
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
EBioMedicine. 2023 Jan;87:104402
pubmed: 36543718
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Cell. 2021 Apr 15;184(8):2183-2200.e22
pubmed: 33756110
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17221-17227
pubmed: 32631992
Nat Commun. 2022 Sep 1;13(1):5135
pubmed: 36050304
Cell. 2021 Nov 11;184(23):5699-5714.e11
pubmed: 34735795
Wellcome Open Res. 2021 Sep 3;6:220
pubmed: 35600250
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Nat Med. 2002 Apr;8(4):379-85
pubmed: 11927944
Lancet Infect Dis. 2022 Jul;22(7):943-945
pubmed: 35691303
N Engl J Med. 2022 Jul 7;387(1):21-34
pubmed: 35704396
Med. 2022 Dec 9;3(12):838-847.e3
pubmed: 36228619
Cell. 2023 May 25;186(11):2392-2409.e21
pubmed: 37164012
Nucleic Acids Res. 2023 Jan 6;51(D1):D1053-D1060
pubmed: 36350643